COLUMBUS, Ohio-Labcorp has introduced a groundbreaking blood test for pregnant individuals during the first trimester to assess the risk of preeclampsia, a potentially life-threatening complication. The test, available between 11 and 14 weeks gestation, evaluates the likelihood of developing preeclampsia before 34 weeks of pregnancy.
The screening test aims to aid in early identification of high-risk pregnancies, potentially enabling preventive measures for better maternal outcomes. Although not a diagnostic tool, the test guides adjustments in prenatal care based on risk assessment results. Labcorp is working to ensure insurance coverage for the test, priced at approximately $240, to make it accessible to pregnant individuals nationwide.
https://www.wlwt.com/article/preeclampsia-screening-tool/60799107
